Holen Sie sich die Stockscreener-App
34.71
3.24%
1.09
Vorhandelsmarkt:
35.19
0.48
+1.38%
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Novo Nordisk Just Took a Big Swing, Slashing Its GLP-1 Drug Prices. Will It Pay Off for the Healthcare Giant? - The Motley Fool
Hims & Hers health authorizes $250 million share repurchase program - MSN
How Novo Nordisk Is Trying to Regain Its Weight-Loss Edge - Bloomberg.com
Hims & Hers Accelerates Its Clinician-Led, Platform-Driven Care Model - Yahoo Finance
Hims & Hers Health Options Trading: A Deep Dive into Market Sentiment - Benzinga
OMCL or HIMS: Which Is the Better Value Stock Right Now? - sharewise.com
Hims & Hers Health: A Notable Shift Toward Core - Smartkarma
Hims & Hers Health Announces New Share Buyback Program - MSN
HIMS Has Been a Roller Coaster Ride. Should Investors Hop On? - MarketBeat
Hims & Hers Health Insider Sold Shares Worth $853,490, According to a Recent SEC Filing - MarketScreener
Hims & Hers Health Stock (HIMS) Opinions on Q3 Earnings and Competitive Challenges - Quiver Quantitative
Hers Health Inc. stock surprise with earnings upside2025 Geopolitical Influence & Weekly Breakout Watchlists - newser.com
Analysts Have Conflicting Sentiments on These Healthcare Companies: NRX Pharmaceuticals (NRXP), LifeMD (LFMD) and Hims & Hers Health (HIMS) - The Globe and Mail
Parents Sue Hims After Washington State Student’s Suicide - USA Herald
Hims & Hers Plunges 15.6% in 3 Months: Time to Hold the Stock or Sell? - TradingView
Commit To Purchase Hims & Hers Health At $20, Earn 27.2% Using Options - Nasdaq
Is Trending Stock Hims & Hers Health, Inc. (HIMS) a Buy Now? - Yahoo Finance
The Price Is Right For Hims & Hers Health, Inc. (NYSE:HIMS) Even After Diving 29% - simplywall.st
Telehealth Co. Hims Sued Over College Student's Suicide - Law360
Key facts: Hims & Hers shares fall 4.9%; Deb Autor appointed Chief Policy Officer - TradingView
Hims & Hers Stock Falls Amid Weight-Loss Drug Price CompetitionNews and Statistics - IndexBox
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today - Finviz
What's Going On With Hims & Hers Health Shares Monday? - Benzinga
Hims & Hers Health board approves $250 million share repurchase program - Investing.com Nigeria
Hims & Hers Health stock rises after announcing $250 million buyback program - MSN
Hims & Hers names ex-FDA official Deb Autor as first policy chief - Reuters
Hims & Hers Health, Inc. Appoints Deb Autor as the First Chief Policy Officer - MarketScreener
Hims & Hers Announces New $250 Million Share Repurchase Program – Retail Sees A Steady Trading Range For The Stock - Stocktwits
Hims & Hers Health effects new up to $250M stock buyback program, shares up ~2% - MSN
Hims & Hers Health effects new up to $250M stock buyback program, shares up ~2% (HIMS:NYSE) - Seeking Alpha
Hims & Hers announces $250 million share repurchase program - Investing.com India
Hims & Hers Health Announces New Share Repurchase Program - TradingView
Hims & Hers Health, Inc. Announces $250 Million Share Repurchase Program Authorization - Hims Investor Relations
Hims & Hers appoints former FDA leader Deb Autor as first CPO - Investing.com Canada
Hims & Hers Names Deb Autor as Chief Policy Officer to Lead Global Policy and Regulatory Strategy - The AI Journal
Hims & Hers appoints former FDA leader Deb Autor as first CPO By Investing.com - Investing.com South Africa
Why I’m Joining Hims & Hers - Hims & Hers Newsroom
Hims & Hers Launches ‘Labs’ to Expand Into Data-Driven Diagnostics - Global Cosmetics News
Hims & Hers Health’s Valuation in Focus After Wrongful Death Lawsuit Raises New Questions - Yahoo Finance
Hims & Hers Enters Direct-to-Consumer Lab Testing %%sep%% %%sitename%% - Newsweek
Hims & Hers Introduces Labs With Annual Plans For Comprehensive Testing - Benzinga
Family Alleges Hims & Hers Health, Inc.’s Rush Into Mental Healthcare Violated Washington Law and Resulted in Son’s Death - The Manila Times
Family Alleges Hims & Hers Health, Inc.’s Rush Into Mental - GlobeNewswire
Hims & Hers Health Stock (HIMS) Opinions on Q3 Earnings and New Platform Launch - Quiver Quantitative
Why Hims & Hers Health Shares Are Sliding - TipRanks
1 Healthcare Stock to Consider Right Now and 2 Facing Headwinds - Finviz
Hims & Hers Stock Logs 3-Day Losing Streak As Truist Calls Out Klarna GLP-1 Changes — Retail Sees Fresh Buy Zone - Stocktwits
Hims & Hers Stock Plunge: Expansion Fails to Impress Investors - AD HOC NEWS
Hims & Hers Bets on Lab Testing to Boost Growth - The Wall Street Journal
Health Care Flat as Traders Rotate Into Sectors Less Dependent on AI Boom -- Health Care Roundup - MarketWatch
Family of WSU student files wrongful death lawsuit against Hims & Hers over antidepressant prescription - NonStop Local KHQ
Family of WSU student who died by suicide in 2023 sues Hims & Hers Health, Theta Chi fraternity for wrongful death - KREM
Key facts: Hims & Hers Health expands telehealth services; Officer sells shares - TradingView
4.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):